|
시장보고서
상품코드
1846086
블로우 필 씰 기술 시장 : 제품 유형, 재료 유형, 최종 이용 산업, 지역별(2024-2031년)Blow-Fill-Seal Technology Market by Product Type (Bottles, Vials, Ampoules, Pre-filled Syringes & Injectables), Material Type (Polypropylene, Polyethylene), End-User Industry (Pharmaceutical, Food & Beverages), & Region for 2024- 2031 |
||||||
제약 산업에서 무균적이고 안전한 포장 옵션에 대한 수요 증가가 블로우 필 씰(BFS) 기술 시장의 주요 촉진 요인으로 작용하고 있습니다. 이 기술은 블로우, 충전, 밀봉 작업을 하나의 자동화된 시스템으로 통합하여 생산 효율성을 높이는 동시에 오염 우려를 줄여, 제약 및 식품 산업 모두에게 약물 전달 및 포장에서의 중대한 과제를 해결합니다. Verified Market Research의 애널리스트에 따르면, 블로우 필 씰 기술 시장은 2024년 약 603억 5,000만 달러 미만으로 시작하여 예측 기간 동안 2,956억 1,000만 달러 규모에 이를 것으로 추정됩니다.
만성질환의 증가와 이에 따른 주사제 필요성의 증가, 환자의 안전과 컴플라이언스 강화는 블로우필씰(BFS) 기술 시장을 발전시키는 주요 요인으로 작용하고 있습니다. 이에 따라 이 시장은 2024년부터 2031년까지 CAGR 21.97%로 성장할 것으로 예상됩니다.
블로우 필 씰 기술 시장 정의/개요
블로우필씰(BFS) 기술은 플라스틱 용기를 연속적으로 성형, 충전, 밀봉하는 무균 액체 제품 포장의 자동 제조 기술입니다. 이 기술은 열가소성 튜브를 필요한 용기 모양으로 불어넣고, 제품을 채우고, 무균 및 제품 무결성을 유지하기 위해 밀봉하는 세 가지 주요 공정으로 구성됩니다. BFS 기술은 오염 위험 감소, 생산 비용 절감, 유통기한 연장 등의 장점으로 인해 제약 업계에서 주사제, 백신, 점안액, 기타 무균 액체 제제 등 다양한 제품 포장에 널리 사용되고 있습니다.
제약 산업은 블로우필씰(BFS) 기술 시장의 주요 촉진요인입니다. FDA 보고서에 따르면 2023년 신약 승인은 전년 대비 13% 증가할 것으로 예상되며, 그 중 상당수는 무균 포장 솔루션을 필요로 합니다. BFS 기술은 무균 일회용 용기를 생산할 수 있기 때문에 이러한 증가하는 수요를 충족시키기에 적합합니다.
지속가능성은 포장 결정에 있어 중요한 고려사항이 되고 있습니다. 유럽 플라스틱 협정(European Plastics Pact)에 따르면, BFS 기술은 표준 포장 방법보다 플라스틱을 최대 40%까지 절약할 수 있다고 합니다. 이는 2030년까지 모든 플라스틱 포장을 재활용 또는 재사용할 수 있도록 하겠다는 유럽연합의 목표와 일치합니다.
또한, 식음료 업계에서는 1회용 제품을 포장하기 위해 BFS 기술을 사용하는 경우가 증가하고 있습니다. 세계식품안전이니셔티브(GFSI)는 2020년부터 2023년까지 식품 사업에서 BFS를 포함한 무균 포장 기술 사용률이 22% 증가할 것이라고 보고했습니다. 이러한 추세는 더 긴 유통기한과 더 높은 식품 안전에 대한 요구가 원동력이 되고 있습니다.
BFS 기기 및 장비에 소요되는 초기 비용이 비싸기 때문에 이 기술을 도입하려는 신규 진입 기업이나 중소기업에게는 큰 장벽이 되고 있습니다. BFS 시스템은 복잡하기 때문에 많은 자본 투자가 필요하며, 특히 자금 조달이 어려운 저개발 국가에서는 시장 확대가 제한됩니다.
또한 BFS 기술은 액체 및 반 액체 재료의 포장에 가장 적합하기 때문에 더 큰 포장 요구 사항에 대한 적용이 제한됩니다. 이러한 제약으로 인해 고체 또는 분말 제형이 일반적인 산업 및 응용 분야에서는 BFS 시스템의 사용이 제한되어 전체 시장 확대에 방해가 될 수 있습니다.
The growing need for sterile and safe packaging options in the pharmaceutical industry is the main driver of the blow-fill-seal (BFS) technology market. This technology combines the blowing, filling, and sealing operations into a single automated system, increasing production efficiency while reducing contamination concerns, thereby addressing significant difficulties in drug delivery and packaging for both the pharmaceutical and food industries. According to the analyst from Verified Market Research, the blow-fill-seal technology market is estimated to reach a valuation of USD 295.61 Billion over the forecast subjugating around USD 60.35 Billion valued in 2024.
The rising prevalence of chronic diseases and the resulting need for injectable drugs, combined with a growing emphasis on patient safety and compliance, are key factors propelling the blow-fill-seal (BFS) technology market forward. It enables the market to grow at a CAGR of 21.97% from 2024 to 2031.
Blow-Fill-Seal Technology Market: Definition/Overview
Blow-Fill-Seal (BFS) technology is an automated manufacturing technique for aseptic liquid product packaging that involves continuously forming, filling, and sealing plastic containers. This technology consists of three major steps: blowing a thermoplastic tube into the required container shape, filling it with the product, and hermetically sealing it to maintain sterility and product integrity. BFS technology is widely used in the pharmaceutical industry to package a variety of products, including injectable medications, vaccines, ophthalmic solutions, and other sterile liquid formulations, due to its benefits in reducing contamination risks, lowering production costs, and increasing shelf life.
The pharmaceutical industry is a key driver of the blow-fill-seal (BFS) technology market. According to an FDA report, new medicine approvals increased by 13% in 2023 compared to the previous year, with many requiring sterile packaging solutions. The BFS technology's capacity to manufacture sterile, single-dose containers makes it suitable for meeting this expanding need.
Sustainability is becoming an important consideration in packaging decisions. According to the European Plastics Pact, BFS technology can save up to 40% more plastic than standard packaging methods. This coincides with the European Union's goal of making all plastic packaging recyclable or reused by 2030.
Furthermore, the food and beverage industry is increasingly using BFS technology to package single-serve items. The Global Food Safety Initiative (GFSI) reported a 22% rise in the usage of aseptic packaging techniques, including BFS, in the food business between 2020 and 2023. This trend is driven by the desire for longer shelf life and higher food safety.
The high initial costs involved with BFS gear and equipment create a substantial barrier for new entrants and smaller businesses seeking to implement this technology. The complexity of BFS systems necessitates significant capital expenditure, limiting market expansion, particularly in underdeveloped countries with limited access to funding.
Furthermore, the BFS technology is best suited for packaging liquid and semi-liquid materials, which limits its application to larger packaging requirements. This constraint limits the use of BFS systems in industries or applications where solid or powdered formulations are more common, potentially impeding overall market expansion.
According to VMR analyst, the bottle segment is anticipated to dominate the segment within the blow-fill-seal technology market during the forecast period. BFS technology enables the production of bottles in a variety of sizes and forms, meeting the unique packaging needs of industries such as medicines, food, and cosmetics. This adaptability helps producers to address specific product requirements while also improving consumer convenience.
Bottles are commonly used to package liquid drugs such as eye drops, nasal sprays, and oral solutions. The growing need for sterile packaging solutions in the pharmaceutical industry is a major driver of the growth of the bottles segment in the BFS technology market.
Furthermore, ongoing research and development activities are aimed at increasing machine efficiency, optimizing packaging designs, and discovering novel materials that are compatible with BFS technology. These advances are projected to improve the capabilities and usage of BFS bottles, accelerating segment growth in the next years.
The pharmaceutical segment is estimated to hold the largest share of the blow-fill-seal technology market during the forecast period. The pharmaceutical industry is experiencing an increase in demand for sterile packaging solutions as injectable medications and biologics become more common. BFS technology provides an effective means for making containers that reduce contamination risks, ensure product safety, and comply with high regulatory criteria, resulting in its widespread application in this market.
The fast growth of biologics and injectable drugs is a major driver in the pharmaceutical BFS market. Because these treatments require particular packaging to retain their efficacy and sterility, BFS technology offers a suitable solution by combining the processes of container construction, filling, and sealing, catering precisely to the needs of these sensitive formulations.
Furthermore, patient safety and medication adherence are becoming increasingly important in the healthcare business. This approach is supported by BFS technology, which allows for the creation of single-dose containers that improve dosage accuracy and lower the risk of contamination, resulting in better patient outcomes and increased demand in the pharmaceutical market.
North America is estimated to exhibit substantial growth during the forecast period. From 2020 to 2023, the United States Food and Medicine Administration (FDA) reported a 15% rise in medicine recalls owing to packaging concerns. This has resulted in a wider use of BFS technology in North America, as it reduces the danger of contamination while improving product integrity. The FDA also reported that BFS-packaged products had 30% fewer recalls than standard packaging methods during the same period.
The North American biopharmaceutical market has been rapidly expanding. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the United States alone has over 800 biologics in development as of 2023, representing a 25% increase from 2020. These sensitive items require aseptic packing, which BFS technology excels at.
Furthermore, the North American healthcare system is moving toward unit-dose packaging to increase patient safety and prevent pharmaceutical mistakes. According to the American Society of Health-System Pharmacists (ASHP), the percentage of hospitals that use unit-dose systems has climbed from 68% in 2020 to 83% in 2023. BFS technology is suited for making such single-dose containers, which has fueled its development in the region.
The Asia Pacific is estimated to dominate the blow-fill-seal technology market during the forecast period. The Asia Pacific pharmaceutical market has been rapidly expanding. According to an International Trade Administration estimate, the pharmaceutical industry in Asia Pacific was valued at USD 365 Billion in 2022, with a compound annual growth rate (CAGR) of 8.4% through 2027. This increase is fueling demand for innovative packaging technologies such as Blow-Fill-Seal.
Many Asian countries are boosting healthcare spending and launching programs to improve healthcare infrastructure. The World Health Organization reported that healthcare spending in Southeast Asia climbed from 3.5% of GDP in 2010 to 4.9% in 2023. This increasing investment is accelerating the implementation of new medical technology, such as BFS for pharmaceutical packaging.
Furthermore, with increasing concerns about product safety and contamination, there is a greater demand for sterile packaging solutions. From 2020 to 2023, the China Food and Drug Administration reported a 30% growth in the deployment of aseptic packaging technologies, including BFS, in the pharmaceutical and healthcare sectors. This trend is especially prevalent in nations with substantial generic medicine manufacturing sectors, such as India and China.
The competitive landscape of the blow-fill-seal (BFS) technology market is characterized by fierce competition among multiple domestic and international competitors vying for market dominance in a constantly expanding sector. Companies are increasingly relying on strategic activities like mergers, acquisitions, and partnerships to improve their technology skills and broaden their product offerings.
Some of the prominent players operating in the blow-fill-seal technology market include:
Syntegon Technology GmbH
Bosch Packaging Technology GmbH
Buhl France SAS
IWK Verpackungstechnik GmbH
Marchesini Group S.p.A.
Romaco Holding GmbH
Nissei ASB Machine Co., Ltd.
Vetter Pharma International GmbH
Bausch + Strobel Maschinenbau GmbH
Optima Machinery GmbH
In December 2021, Woodstock received a US patent for their Cold BFS system. This technique regulates temperature to prevent heat damage, making it excellent for heat-sensitive pharmaceuticals.
In January 2021, Berry Global Healthcare introduced Cyrano, their lightest blow-fill seal closure. It aims to reduce plastic waste and offer a simple solution for all intravenous and infusion systems.
Blow-Fill-Seal Technology Market, by Category
Product Type:
Bottles
Vials
Ampoules
Pre-filled Syringes & Injectables
Material Type:
Polypropylene
Polyethylene
End-User Industry:
Pharmaceutical
Food & Beverages
Others
Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa